MTOR and atherosclerosis: Previous studies reported that oxLDL actives mammalian target of rapamycin (mTOR) in THP-1cell [29], and an activator of mTOR inhibits oxLDL-induced autophagy and restricts atherosclerosis in ApoE-knockout mice [30].